1. FRI0564 Serum Uric Acid Testing Practices over Five Years among Incident Gout Cases. (15th July 2016) Authors: Benis, A.; Jaffe, D.; Flores, N.; Gabay, H.; Morlock, R.; Klein, A.; Teltsch, D.; Chapnick, J.; Feldman, B.; Leventer-Roberts, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0588 Comparing The Burden of Illness of Patients with Tophaceous and Non-Tophaceous Gout in France, Germany, Italy, Spain, and The UK. (15th July 2016) Authors: Khanna, P.; Tafesse, E.; Baumgartner, S.; Walker, A.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0589 The Impact of Gout Flares on Patient-Reported Assessments of Pain and Disability. (15th July 2016) Authors: Khanna, P.; Baumgartner, S.; Robinson, J.; Tafesse, E.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0591 Hyperuricemia and The Risk for Cardiovascular Disease: Individual Patient Meta-Analysis of 77, 045 Individuals Enrolled in 15 Epidemiologic Studies. (15th July 2016) Authors: Baumgartner, S.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0594 Association of Gout Diagnosis with Increased Risk of Joint Replacement: A Population-Based Cohort Study of over 250, 000 Patients. (15th July 2016) Authors: Perreault, S.; Klein, A.B.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0527 Lesinurad, A Selective Uric Acid Reabsorption Inhibitor, in Combination with Xanthane Oxidase Inhibitors: SUA and Flares Composite Endpoint from Phase III Studies in Gout Patients (Clear 1, Clear 2 and Crystal). (15th July 2016) Authors: Khanna, P.P.; Baumgartner, S.; Robinson, J.; Tafesse, E.; Morlock, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗